Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Matthew A Wyczalkowski
Affiliation
Washington University in St Louis
ORCID
Career Start Year
2003
Papers
45
H Index
24
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36779841
Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma.
Cancer Res
2023
37914932
Epigenetic regulation during cancer transitions across 11 tumour types.
Nature
2023
37961519
Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages.
bioRxiv
2023
36973268
Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.
Nat Commun
2023
36779841
Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma.
Cancer Res
2023
37198186
Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.
Nat Commun
2023
37914932
Epigenetic regulation during cancer transitions across 11 tumour types.
Nature
2023
37961519
Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages.
bioRxiv
2023
36973268
Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.
Nat Commun
2023
37198186
Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.
Nat Commun
2023
34996889
Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment.
Nat Commun
2022
35995947
Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer.
Nat Genet
2022
35603231
Pollock: fishing for cell states.
Bioinform Adv
2022
34996889
Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment.
Nat Commun
2022
35603231
Pollock: fishing for cell states.
Bioinform Adv
2022
35995947
Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer.
Nat Genet
2022
33417831
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma.
Cancer Cell
2021
33963182
Co-evolution of tumor and immune cells during progression of multiple myeloma.
Nat Commun
2021
33577785
Proteogenomic and metabolomic characterization of human glioblastoma.
Cancer Cell
2021
33875650
Spatially interacting phosphorylation sites and mutations in cancer.
Nat Commun
2021
33417831
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma.
Cancer Cell
2021
34429404
Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment.
Nat Commun
2021
35121865
Moving pan-cancer studies from basic research toward the clinic.
Nat Cancer
2021
33875650
Spatially interacting phosphorylation sites and mutations in cancer.
Nat Commun
2021
33577785
Proteogenomic and metabolomic characterization of human glioblastoma.
Cancer Cell
2021
35121865
Moving pan-cancer studies from basic research toward the clinic.
Nat Cancer
2021
34429404
Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment.
Nat Commun
2021
33963182
Co-evolution of tumor and immune cells during progression of multiple myeloma.
Nat Commun
2021
32529193
Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability.
Cell Rep Med
2020
31923397
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.
Cell
2020
33149122
Discovery of driver non-coding splice-site-creating mutations in cancer.
Nat Commun
2020
32529193
Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability.
Cell Rep Med
2020
32954372
Correction: Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability.
Cell Rep Med
2020
31923397
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.
Cell
2020
33149122
Discovery of driver non-coding splice-site-creating mutations in cancer.
Nat Commun
2020
32954372
Correction: Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability.
Cell Rep Med
2020
30911684
Dynamic host immune response in virus-associated cancers.
Commun Biol
2019
31675502
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.
Cell
2019
30102335
CharGer: clinical Characterization of Germline variants.
Bioinformatics
2019
30911684
Dynamic host immune response in virus-associated cancers.
Commun Biol
2019
31675502
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.
Cell
2019
30102335
CharGer: clinical Characterization of Germline variants.
Bioinformatics
2019
29625049
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics.
Cell
2018
30053901
Integrative omics analyses broaden treatment targets in human cancer.
Genome Med
2018
30535306
Database of evidence for precision oncology portal.
Bioinformatics
2018
29625052
Pathogenic Germline Variants in 10,389 Adult Cancers.
Cell
2018
29625049
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics.
Cell
2018
29617666
Systematic Analysis of Splice-Site-Creating Mutations in Cancer.
Cell Rep
2018
29617662
Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.
Cell Rep
2018
30053901
Integrative omics analyses broaden treatment targets in human cancer.
Genome Med
2018
1 - 50 of 90
Column Actions
Search
Recommended Authors
Daniel J McGrail
Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic
Career Start Year
2012
Number of shared co-authors
7
Stephanie C Hicks
Johns Hopkins Bloomberg School of Public Health
Career Start Year
2011
Number of shared co-authors
6
Elana J Fertig
Johns Hopkins University School of Medicine
Career Start Year
2010
Number of shared co-authors
3
Geoff Macintyre
CRUK Cambridge Institute, University of Cambridge
Career Start Year
2009
Number of shared co-authors
1
Kathleen M Fisch
Center for Computational Biology and Bioinformatics, University of California
Career Start Year
2009
Number of shared co-authors
0
Michael T Zimmermann
Medical College of Wisconsin
Career Start Year
2009
Number of shared co-authors
8
Ignaty Leshchiner
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year
2008
Number of shared co-authors
1
Eric Paquet
University of Laval
Career Start Year
2007
Number of shared co-authors
0
Xiaotu Ma
St. Jude Children's Research Hospital
Career Start Year
2006
Number of shared co-authors
18
Joshua J Waterfall
INSERM U, PSL Research University, Institut Curie Research Center
Career Start Year
2006
Number of shared co-authors
0
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Career Start Year
2006
Number of shared co-authors
8
Joshua W K Ho
The University of Hong Kong
Career Start Year
2006
Number of shared co-authors
0
Jeroen de Ridder
Center for Molecular Medicine, University Medical Center Utrecht
Career Start Year
2006
Number of shared co-authors
2
Semin Lee
Ulsan National Institute of Science and Technology (UNIST)
Career Start Year
2005
Number of shared co-authors
18
Tommaso Mazza
Fondazione IRCCS Casa Sollievo della Sofferenza,71013
Career Start Year
2005
Number of shared co-authors
0
Armand Bankhead
Rogel Cancer Center, University of Michigan ann arbor
Career Start Year
2005
Number of shared co-authors
7
Jun S Song
University of Illinois at Urbana-Champaign
Career Start Year
2005
Number of shared co-authors
0
Robert Sebra
Icahn School of Medicine at Mount Sinai
Career Start Year
2004
Number of shared co-authors
9
Ted Laderas
Oregon Health & Science University
Career Start Year
2003
Number of shared co-authors
0
Amy G Robertson
Present address: Dxige Research Inc.
Career Start Year
2003
Number of shared co-authors
39
Syed Haider
Institute of Cancer Research
Career Start Year
2002
Number of shared co-authors
7
Osvaldo Gra??a
Spanish National Cancer Research Centre-CNIO
Career Start Year
2002
Number of shared co-authors
0
Reid F Thompson
Oregon Health and Sciences University
Career Start Year
2002
Number of shared co-authors
1
Olivier Elemento
Meyer Cancer Center
Career Start Year
2002
Number of shared co-authors
12
Luciano G Martelotto
Monash University
Career Start Year
2000
Number of shared co-authors
1
Xingzhi Song
The University of Texas MD Anderson Cancer Center
Career Start Year
1998
Number of shared co-authors
21
Alex Kentsis
Memorial Sloan-Kettering Cancer Center
Career Start Year
1998
Number of shared co-authors
1
Roland Eils
Berlin Institute of Health (BIH) and Charite
Career Start Year
1995
Number of shared co-authors
11
Peter Kuhn
University of Tubingen
Career Start Year
1994
Number of shared co-authors
1
Yuval Kluger
Yale University School of Medicine
Career Start Year
1984
Number of shared co-authors
4
row(s) 1 - 30 of 30
Collaborators
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers
31
Michael C Wendl
Washington University in St Louis
Co-authored papers
30
Feng Chen
Washington University in St Louis
Co-authored papers
23
Song Cao
Washington University in St Louis
Co-authored papers
19
Reyka G Jayasinghe
Washington University in St Louis
Co-authored papers
17
Yize Li
Co-authored papers
12
John F DiPersio
Washington University School of Medicine
Co-authored papers
10
Henry Rodriguez
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Co-authored papers
10
Christopher R Kinsinger
Co-authored papers
10
Sam Q Sun
Co-authored papers
9
Kuan-Lin Huang
Icahn School of Medicine at Mount Sinai
Co-authored papers
9
Robert J Mashl
Washington University in St. Louis
Co-authored papers
9
Daniel Cui Zhou
Washington University in St. Louis
Co-authored papers
9
Adam D Scott
McDonnell Genome Institute, Siteman Cancer Center, Washington University in St. Louis
Co-authored papers
9
Michael D McLellan
McDonnell Genome Institute, Washington University in St. Louis
Co-authored papers
9
David Feny??
Institute for Systems Genetics, NYU Grossman School of Medicine
Co-authored papers
9
Kai Ye
Co-authored papers
9
Matthew H Bailey
Department of Biology at Brigham Young University
Co-authored papers
8
Ruiyang Liu
Co-authored papers
8
Benjamin J Raphael
Princeton University
Co-authored papers
8
Joshua F McMichael
Washington University
Co-authored papers
8
Mehdi Mesri
Co-authored papers
8
Wen-Wei Liang
Washington University in St Louis
Co-authored papers
8
Beifang Niu
Co-authored papers
8
Liang-Bo Wang
Washington University in St. Louis
Co-authored papers
8
Nadezhda V Terekhanova
Co-authored papers
8
Ken Chen
University of Texas MD Anderson Cancer Center
Co-authored papers
8
Chia-Kuei Mo
Co-authored papers
7
Daniel W Chan
Division of Clinical Chemistry, Johns Hopkins University
Co-authored papers
7
Wagma Caravan
Co-authored papers
6
1 - 30